BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shibata N, Watanabe T, Okitsu T, Sakaguchi M, Takesue M, Kunieda T, Omoto K, Yamamoto S, Tanaka N, Kobayashi N. Establishment of an immortalized human hepatic stellate cell line to develop antifibrotic therapies. Cell Transplant. 2003;12:499-507. [PMID: 12953924 DOI: 10.3727/000000003108747064] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 饶慧瑛, 魏来. 干扰素对肝星状细胞活化的影响. 世界华人消化杂志 2005; 13(4): 440-442 [DOI: 10.11569/wcjd.v13.i4.440] [Reference Citation Analysis]
2 DeRossi C, Bambino K, Morrison J, Sakarin I, Villacorta-Martin C, Zhang C, Ellis JL, Fiel MI, Ybanez M, Lee YA, Huang KL, Yin C, Sakaguchi TF, Friedman SL, Villanueva A, Chu J. Mannose Phosphate Isomerase and Mannose Regulate Hepatic Stellate Cell Activation and Fibrosis in Zebrafish and Humans. Hepatology 2019;70:2107-22. [PMID: 31016744 DOI: 10.1002/hep.30677] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Anthony B, Allen JT, Li YS, McManus DP. Hepatic stellate cells and parasite-induced liver fibrosis. Parasit Vectors. 2010;3:60. [PMID: 20663176 DOI: 10.1186/1756-3305-3-60] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 5.1] [Reference Citation Analysis]
4 Nahar S, Nakashima Y, Miyagi-Shiohira C, Kinjo T, Toyoda Z, Kobayashi N, Saitoh I, Watanabe M, Noguchi H, Fujita J. Cytokines in adipose-derived mesenchymal stem cells promote the healing of liver disease. World J Stem Cells 2018; 10(11): 146-159 [PMID: 30631390 DOI: 10.4252/wjsc.v10.i11.146] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
5 Cai X, Wang J, Wang J, Zhou Q, Yang B, He Q, Weng Q. Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy. Pharmacol Res 2020;155:104720. [PMID: 32092405 DOI: 10.1016/j.phrs.2020.104720] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 18.0] [Reference Citation Analysis]
6 Kim RS, Hasegawa D, Goossens N, Tsuchida T, Athwal V, Sun X, Robinson CL, Bhattacharya D, Chou HI, Zhang DY, Fuchs BC, Lee Y, Hoshida Y, Friedman SL. The XBP1 Arm of the Unfolded Protein Response Induces Fibrogenic Activity in Hepatic Stellate Cells Through Autophagy. Sci Rep. 2016;6:39342. [PMID: 27996033 DOI: 10.1038/srep39342] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 9.2] [Reference Citation Analysis]
7 Chida T, Ito M, Nakashima K, Kanegae Y, Aoshima T, Takabayashi S, Kawata K, Nakagawa Y, Yamamoto M, Shimano H, Matsuura T, Kobayashi Y, Suda T, Suzuki T. Critical role of CREBH-mediated induction of transforming growth factor β2 by hepatitis C virus infection in fibrogenic responses in hepatic stellate cells. Hepatology 2017;66:1430-43. [PMID: 28621467 DOI: 10.1002/hep.29319] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
8 Watanabe N, Aizaki H, Matsuura T, Kojima S, Wakita T, Suzuki T. Hepatitis C virus RNA replication in human stellate cells regulates gene expression of extracellular matrix-related molecules. Biochem Biophys Res Commun 2011;407:135-40. [PMID: 21371436 DOI: 10.1016/j.bbrc.2011.02.125] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
9 Nakamuta M, Kohjima M, Fukushima M, Morizono S, Kotoh K, Kobayashi N, Enjoji M. Cyclosporine Suppresses Cell Growth and Collagen Production in Hepatic Stellate Cells. Transplantation Proceedings 2005;37:4598-602. [DOI: 10.1016/j.transproceed.2005.10.104] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
10 Shimozono R, Nishimura K, Akiyama H, Funamoto S, Izawa A, Sai T, Kunita K, Kainoh M, Suzuki T, Kawada N. Interferon-β Mediates Signaling Pathways Uniquely Regulated in Hepatic Stellate Cells and Attenuates the Progression of Hepatic Fibrosis in a Dietary Mouse Model. J Interferon Cytokine Res 2015;35:464-73. [PMID: 25715168 DOI: 10.1089/jir.2014.0096] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
11 Rivas-carrillo JD, Okitsu T, Kobayashi N. Current Cell-based Approaches for the Treatment of Diabetes Mellitus. Biotechnology and Genetic Engineering Reviews 2007;24:281-96. [DOI: 10.1080/02648725.2007.10648104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
12 Hara M, Inoue I, Yamazaki Y, Kirita A, Matsuura T, Friedman SL, Rifkin DB, Kojima S. L(59) TGF-β LAP degradation products serve as a promising blood biomarker for liver fibrogenesis in mice. Fibrogenesis Tissue Repair 2015;8:17. [PMID: 26379781 DOI: 10.1186/s13069-015-0034-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
13 Ito N, Nakashima K, Sun S, Ito M, Suzuki T. Cell Type Diversity in Hepatitis B Virus RNA Splicing and Its Regulation. Front Microbiol 2019;10:207. [PMID: 30800119 DOI: 10.3389/fmicb.2019.00207] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
14 Yao XX, Jiang SL, Tang YW, Yao DM, Yao X. Efficacy of Chinese medicine Yi-gan-kang granule in prophylaxis and treatment of liver fibrosis in rats. World J Gastroenterol 2005; 11(17): 2583-2590 [PMID: 15849816 DOI: 10.3748/wjg.v11.i17.2583] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
15 Borlongan CV, Yu G, Matsukawa N, Yasuhara T, Hara K, Xu L. Article Commentary: Cell Transplantation: Stem Cells in the Spotlight. Cell Transplant 2005;14:519-26. [DOI: 10.3727/000000005783982774] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
16 Zhang Y, Guo J, Dong H, Zhao X, Zhou L, Li X, Liu J, Niu Y. Hydroxysafflor yellow A protects against chronic carbon tetrachloride-induced liver fibrosis. European Journal of Pharmacology 2011;660:438-44. [DOI: 10.1016/j.ejphar.2011.04.015] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
17 Popov Y, Schuppan D. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology. 2009;50:1294-1306. [PMID: 19711424 DOI: 10.1002/hep.23123] [Cited by in Crossref: 214] [Cited by in F6Publishing: 222] [Article Influence: 17.8] [Reference Citation Analysis]
18 Herrmann J, Gressner AM, Weiskirchen R. Immortal hepatic stellate cell lines: useful tools to study hepatic stellate cell biology and function? J Cell Mol Med 2007;11:704-22. [PMID: 17760834 DOI: 10.1111/j.1582-4934.2007.00060.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 4.6] [Reference Citation Analysis]
19 Shang L, Hosseini M, Liu X, Kisseleva T, Brenner DA. Human hepatic stellate cell isolation and characterization. J Gastroenterol 2018;53:6-17. [PMID: 29094206 DOI: 10.1007/s00535-017-1404-4] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 10.8] [Reference Citation Analysis]
20 Hicks DF, Goossens N, Blas-García A, Tsuchida T, Wooden B, Wallace MC, Nieto N, Lade A, Redhead B, Cederbaum AI, Dudley JT, Fuchs BC, Lee YA, Hoshida Y, Friedman SL. Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells. Sci Rep 2017;7:42563. [PMID: 28256512 DOI: 10.1038/srep42563] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
21 聂青和. 肝纤维化的逆转策略及研究现状. 世界华人消化杂志 2005; 13(10): 1165-1174 [DOI: 10.11569/wcjd.v13.i10.1165] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
22 van Dijk F, Hazelhoff CM, Post E, Prins GGH, Rombouts K, Poelstra K, Olinga P, Beljaars L. Design of a Gene Panel to Expose the Versatile Role of Hepatic Stellate Cells in Human Liver Fibrosis. Pharmaceutics 2020;12:E278. [PMID: 32244897 DOI: 10.3390/pharmaceutics12030278] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Crespo Yanguas S, Cogliati B, Willebrords J, Maes M, Colle I, van den Bossche B, de Oliveira CP, Andraus W, Alves VA, Leclercq I. Experimental models of liver fibrosis. Arch Toxicol. 2016;90:1025-1048. [PMID: 26047667 DOI: 10.1007/s00204-015-1543-4] [Cited by in Crossref: 108] [Cited by in F6Publishing: 107] [Article Influence: 18.0] [Reference Citation Analysis]
24 Biecker E, De Gottardi A, Neef M, Unternährer M, Schneider V, Ledermann M, Sägesser H, Shaw S, Reichen J. Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis: analysis of the underlying mechanisms. J Pharmacol Exp Ther. 2005;313:952-961. [PMID: 15769867 DOI: 10.1124/jpet.104.079616] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 3.8] [Reference Citation Analysis]
25 Azparren-Angulo M, Royo F, Gonzalez E, Liebana M, Brotons B, Berganza J, Goñi-de-Cerio F, Manicardi N, Abad-Jordà L, Gracia-Sancho J, Falcon-Perez JM. Extracellular vesicles in hepatology: Physiological role, involvement in pathogenesis, and therapeutic opportunities. Pharmacol Ther 2021;218:107683. [PMID: 32961265 DOI: 10.1016/j.pharmthera.2020.107683] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Fukushima M, Nakamuta M, Kohjima M, Kotoh K, Enjoji M, Kobayashi N, Nawata H. Fasudil hydrochloride hydrate, a Rho-kinase (ROCK) inhibitor, suppresses collagen production and enhances collagenase activity in hepatic stellate cells. Liver Int. 2005;25:829-838. [PMID: 15998434 DOI: 10.1111/j.1478-3231.2005.01142.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
27 Parekkadan B, van Poll D, Megeed Z, Kobayashi N, Tilles AW, Berthiaume F, Yarmush ML. Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem Biophys Res Commun. 2007;363:247-252. [PMID: 17869217 DOI: 10.1016/j.bbrc.2007.05.150] [Cited by in Crossref: 168] [Cited by in F6Publishing: 173] [Article Influence: 12.0] [Reference Citation Analysis]
28 Higashi N, Kohjima M, Fukushima M, Ohta S, Kotoh K, Enjoji M, Kobayashi N, Nakamuta M. Epigallocatechin-3-gallate, a green-tea polyphenol, suppresses Rho signaling in TWNT-4 human hepatic stellate cells. J Lab Clin Med. 2005;145:316-322. [PMID: 15976760 DOI: 10.1016/j.lab.2005.03.017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
29 Kohjima M, Enjoji M, Higuchi N, Kotoh K, Kato M, Takayanagi R, Nakamuta M. NIM811, a nonimmunosuppressive cyclosporine analogue, suppresses collagen production and enhances collagenase activity in hepatic stellate cells. Liver Int 2007;27:1273-81. [PMID: 17919240 DOI: 10.1111/j.1478-3231.2007.01560.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
30 Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27-42. [PMID: 28506744 DOI: 10.1016/j.addr.2017.05.007] [Cited by in Crossref: 359] [Cited by in F6Publishing: 356] [Article Influence: 89.8] [Reference Citation Analysis]
31 Deshmukh M, Nakagawa S, Higashi T, Vincek A, Venkatesh A, Ruiz de Galarreta M, Koh AP, Goossens N, Hirschfield H, Bian CB, Fujiwara N, Ono A, Hoshida H, El-Abtah M, Ahmad NB, Lujambio A, Sanchez R, Fuchs BC, Poelstra K, Prakash J, Hoshida Y; Precision Liver Cancer Prevention Consortium. Cell type-specific pharmacological kinase inhibition for cancer chemoprevention. Nanomedicine 2018;14:317-25. [PMID: 29157977 DOI: 10.1016/j.nano.2017.11.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
32 Breitkopf K, Weng H, Dooley S. TGF-β/Smad-signaling in liver cells: Target genes and inhibitors of two parallel pathways. Signal Transduction 2006;6:329-37. [DOI: 10.1002/sita.200600097] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
33 Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125-72. [PMID: 18195085 DOI: 10.1152/physrev.00013.2007] [Cited by in Crossref: 1682] [Cited by in F6Publishing: 1628] [Article Influence: 129.4] [Reference Citation Analysis]
34 Gutiérrez-Ruiz MC, Gómez-Quiroz LE. Liver fibrosis: searching for cell model answers. Liver Int. 2007;27:434-439. [PMID: 17403182 DOI: 10.1111/j.1478-3231.2007.01469.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
35 Wallace K, Burt AD, Wright MC. Liver fibrosis. Biochem J. 2008;411:1-18. [PMID: 18333835 DOI: 10.1042/bj20071570] [Cited by in Crossref: 217] [Cited by in F6Publishing: 110] [Article Influence: 16.7] [Reference Citation Analysis]
36 Sanberg PR, Greene-zavertnik C, Davis CD. Article Commentary: Cell Transplantation: The Regenerative Medicine Journal. A Biennial Analysis of Publications. Cell Transplant 2003;12:815-25. [DOI: 10.3727/000000003771000165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]